Titlebook: Emerging Strategies in Neuroprotection; Paul J. Marangos,Harbans Lal Book 1992 Birkh?user Boston 1992 Evolution.biology.brain.neuroscience

BLA

招待

頭腦冷靜

饒舌的人

,Einführung in die Welt des Neuromarketing,nues to be used in the head-injured patient for the control of increased intracranial pressure that is refractory to hyperventilation, ventricular drainage, osmotherapy, and barbiturates. Conversely, the adjunctive chemotherapeutic effect of selective brain tumor hyperthermia remains under intense investigation.

下垂

SCORE

憤怒事實(shí)

EXALT

Primary Cultures for Testing Neuroprotective Drugsure systems and their characteristics. Then we shall discuss various possible ways to experimentally induce and measure neuronal damage in these cultures in analogy to ischemic damage in vivo. Several examples of neuroprotective drug effects demonstrated in vitro will be reviewed.

Felicitous

Stroke Models for Preclinical Trials of Neuroprotective Agentsmal stroke models (Graham, 1988; Molinari, 1988; Wiebers et al., 1990; Zivin and Grotta, 1990). An important issue, i.e., the quality of animal trials, however, has not been adequately addressed previously and will be the main focus of this review.

字形刻痕

Membrane-Derived Lipid Second Messengers as Targets for Neuroprotection: Platelet-Activating Factorrg et al., 1990), and experimental allergic encephalomyelitis (Howat et al., 1989). Recent evidence shows a role for PAF in the release of excitatory amino acid neurotransmitters (Clark et al., 1991) and in long-term potentiation (Del Cerro et al., 1990).